jeudi 30 août 2018

Onco Actu du 30 août 2018

1. Biologie

Cancer Cells Are Even Worse Than We Thought [In the Pipeline]

2.10 Etiologie - Alcool

Is one drink per day really unsafe? That new alcohol study, explained. [Vox]

3.1.1 Prévention - Tabac - e-cigs

Did Juul Lure Teenagers and Get ‘Customers for Life’? [NY Times]

3.3 Prévention - Vaccins

Vaccine tied to drop in HPV cases still not reaching half of U.S. kids [Reuters]

3.8 Prévention - Alimentation

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s support for exempting coffee from California’s cancer warning law [FDA]

Coffee Doesn't Deserve California’s Cancer Risk Warning, FDA Says [Bloomberg]

4.12 Biopsies liquides

Genetic ‘weather forecasting’ could predict bowel cancer’s response to treatment [Institute of Cancer Research]

4.9 Dép., diag. & prono. - Sein

CNIO researchers find the first indicators of prognosis for the most aggressive type of breast cancer [CNIO]

5.1 Traitements - Pré-clinique

A “non-canonical” strategy may improve cancer radiotherapy [University of Chicago]

5.12 Immunothérapies

Researchers lay the foundation for personalized immune treatments for leukemia [UNC]

Combination approach shows promise for beating advanced melanoma [UCLA]

5.12.5 Immunothérapies - Pharma

Novartis to create 450 new jobs at Aargau site after Kymriah thumbs up [Pharmafile]

5.2 Pharma

Sophiris says it’s ready to get back on track with lead drug after patient death — but questions linger [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

FDA Launches Pilot Program in Support of Complex Trial Designs for Drugs and Biologics [RAPS]

FDA’s Comprehensive Effort to Advance New Innovations: Initiatives to Modernize for Innovation [FDA Voice]

5.3.4 Traitements - AMM (FDA, EMA,...)

European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia [Amgen]

5.4 Traitements - Economie

NICE u-turn recommends Ipsen’s Cabometyx for kidney cancer [Pharma Times]

6.1 Observation

Study Provides Closer Look at Postmenopausal Bleeding and Endometrial Cancer [NCI]

6.3 Associations/Fondations

Sir Harpal Kumar: A spotlight on 15 years of progress against cancer [Cancer Research UK]

6.5 Médecines alternatives/complémentaires

NIH names Dr. Helene Langevin director of the National Center for Complementary and Integrative Health [NIH]

6.6 Publications

Opening up peer review [Nature]

6.7.1 IA/bioinformatique

With an eye to AI and autonomous diagnosis [npj Digital Medicine]

6.7.3 DMP

Using a New EHR System to Increase Patient Engagement, Improve Efficiency, and Decrease Cost [NEJM Catalyst]

6.9 Controverses

Bosses at leading UK science institute accused of bullying staff [The Guardian]